» Articles » PMID: 22004770

Different Methods for Ethical Analysis in Health Technology Assessment: an Empirical Study

Overview
Date 2011 Oct 19
PMID 22004770
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Ethical analysis can highlight important ethical issues related to implementing a technology, values inherent in the technology itself, and value-decisions underlying the health technology assessment (HTA) process. Ethical analysis is a well-acknowledged part of HTA, yet seldom included in practice. One reason for this is lack of knowledge about the properties and differences between the methods available. This study compares different methods for ethical analysis within HTA.

Methods: Ethical issues related to bariatric (obesity) surgery were independently evaluated using axiological, casuist, principlist, and EUnetHTA models for ethical analysis within HTA. The methods and results are presented and compared.

Results: Despite varying theoretical underpinnings and practical approaches, the four methods identified similar themes: personal responsibility, self-infliction, discrimination, justice, public funding, and stakeholder involvement. The axiological and EUnetHTA models identified a wider range of arguments, whereas casuistry and principlism concentrated more on analyzing a narrower set of arguments deemed more important.

Conclusions: Different methods can be successfully used for conducting ethical analysis within HTA. Although our study does not show that different methods in ethics always produce similar results, it supports the view that different methods of ethics can yield relevantly similar results. This suggests that the key conclusions of ethical analyses within HTA can be transferable between methods and countries. The systematic and transparent use of some method of ethics appears more important than the choice of the exact method.

Citing Articles

The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting.

Charlton V, DiStefano M J Med Ethics. 2024; 50(12):835-840.

PMID: 38373831 PMC: 11672008. DOI: 10.1136/jme-2023-109467.


[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].

Calabro G, Vitale F, Rizzo C, Pugliese A, Boccalini S, Bechini A J Prev Med Hyg. 2023; 64(1 Suppl 1):E1-E160.

PMID: 37655211 PMC: 10468156. DOI: 10.15167/2421-4248/jpmh2023.64.1s1.


Defending explicability as a principle for the ethics of artificial intelligence in medicine.

Adams J Med Health Care Philos. 2023; 26(4):615-623.

PMID: 37642834 PMC: 10725847. DOI: 10.1007/s11019-023-10175-7.


A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies.

Hoxhaj I, Govaerts L, Simoens S, Van Dyck W, Huys I, Gutierrez-Ibarluzea I Int J Environ Res Public Health. 2020; 17(21).

PMID: 33143182 PMC: 7663163. DOI: 10.3390/ijerph17218001.


The Ethics of Precision Rationing: Human Genetics and the Need for Debate on Stratifying Access to Medication.

Walker A, Boyce A, Duggal P, Thio C, Geller G Public Health Genomics. 2020; 23(3-4):149-154.

PMID: 32516789 PMC: 7508798. DOI: 10.1159/000508141.